The problems presented by patients with asthma who develop transient or variable radiographic shadows in their lungs associated with eosinophilia in the blood are confusing, not only because the observed phenomena are complex and incompletely understood, but also because of the wide variety of verbal usages that have been adopted for their description. In order to minimize the latter source of confusion, I shall start by making statements, which I hope will be clear and unequivocal, about the senses in which I shall use certain key words and phrases.
Definition
Asthma is defined primarily in terms of a specified disorder of function, as a disease characterized by dyspnoea due to widespread narrowing of intrapulmonary airways which varies in severity over short periods of time either spontaneously or as a result of treatment.
Among patients with this disorder of function, it is useful to recognize some sub-groups. The most clearly distinguishable of these is that in which antigen-antibody reactions of reaginic type can be shown to underlie narrowing of airways. Patients in this group have an inborn liability to develop reaginic antibodies in response to the sort of exposure to relevant antigens which occurs in everyday life. These antibodies are present in the blood serum; they become attached to the surface of certain tissue cells, where their reaction with antigen leads to release of pharma-cologically active substances. In the bronchi these cause narrowing of airways, and in skin tests immediate weal-and-flare reactions. Reaginic antibodies can be passively transferred to the skin of normal individuals by injection of the serum of sensitized subjects (the Prausnitz-Kustner reaction). Recently, they have been shown to belong to a special class of immunoglobulins, IgE (Bennich et al. 1968 ). There is evidence that about 10% of people have a special liability to produce such antibodies; these have been described as 'atopic' subjects. When such people develop asthma, it generally starts in childhood or early adult life, and is often associated with other 'allergic' diseases, notably infantile eczema and hay fever. This sort of asthma can be called 'extrinsic' to indicate that an external agent is believed to precipitate the attacks and 'atopic' to indicate the type of hypersensitivity which is concerned.
The term 'intrinsic asthma' can usefully be applied to another sub-group, distinguishable principally on clinical criteria. In the clinical history, patients in this sub-group show no evidence of hypersensitivity to inhaled or ingested substances (apart from a few who are sensitive to aspirin); and in skin tests with the common inhalant allergens, most of them show a remarkable absence of weal-and-flare reactions. This type of asthma may develop at any age, but in many instances it appears for the first time in adults who have had no previous respiratory symptoms. It gives rise to more continuous symptoms than are usual in extrinsic atopic asthma, and often responds satisfactorily only to corticosteroid or corticotrophin treatment. There is good reason to suppose that antigen-antibody reactions of some sort underlie 'intrinsic' asthma, but none has as yet been demonstrated. They are evidently not of reaginic type, and may well be of more than one type.
The 'extrinsic atopic' and 'intrinsic' groups are not mutually exclusive, since a few patients show features of both groups. Nor are they comprehensive, since some cases of asthma cannot be categorized in either of them. Some of these may be attributable to precipitin-mediated Type III reactions to inhaled allergens, and can be described as instances of 'extrinsic non-atopic asthma' (Pepys 1967) . But most of the cases I shall describe conformed well to either the extrinsic atopic or the intrinsic group; I shall draw attention to the few presenting equivocal features.
Eosinophilic Infiltrations of the Lungs The term 'eosinophilic infiltration' can conveniently be used to refer to bronchopulmonary changes producing transient or variable radiographic shadows accompanied by eosinophilia in the peripheral blood and in the sputum, the lung changes and the eosinophilia being thought to be related to each other.
'Eosinophilic infiltration', so defined, may be regarded as synonymous with 'pulmonary eosinophilia', suggested by Crofton et al. (1952) , or 'pulmonary infiltration with eosinophilia' or 'PIE syndrome', suggested by Reeder & Goodrich (1952) . As will be seen later, when histological examination has been possible the lung changes in such cases have generally been found to include inflammatory consolidation with many eosinophils in alveolar exudate and in the walls of alveoli, blood vessels and bronchi. Such changes can be described as 'eosinophilic pneumonia'. I will use this term only when histological evidence is available; a diagnosis of 'eosinophilic infiltration' may be regarded as indicating the inference, on grounds short of biopsy, that lung shadows observed in the living patient are caused by an eosinophilic pneumonia.
Well-recognized varieties of eosinophilic infiltrations are those associated with Ascaris infestation; so-called 'tropical eosinophilia' and related conditions thought to be due to infection with filarix whose normal host is an animal other than man; and drug reactions. These are outside the scope of the present discussion.
Asthma and Eosinophilic Infiltrations
In temperate climates, eosinophilic infiltrations occur most frequently, though by no means always, in patients with asthma. It must be remembered that asthmatic patients may have a moderate eosinophilia, and that, like other people, they are liable to inflammatory changes associated with the common respiratory infec-tions. Such changes must be excluded before radiographic shadows in the lungs of a patient with asthma who has a blood eosinophilia can be regarded as eosinophilic infiltration.
Eosinophilic infiltrations occur in both extrinsic and intrinsic asthmatics. Their clinical, immunological and radiological features differ in these two groups. Much is known of the pathogenesis of eosinophilic infiltrations in extrinsic asthmatics; at least a high proportion of them in Great Britain can be related to Aspergillus fumigatus. The eosinophilic infiltrations occurring in intrinsic asthmatics are of unknown pathogenesis, and differ in clinical and radiological features from those in extrinsic asthmatics. It is my principal purpose to describe, and discuss the implications of, these differences between eosinophilic infiltrations in extrinsic and in intrinsic asthmatics.
Eosinophilic Infiltrations in
Extrinsic Atopic Asthmatics The common mould Aspergillus, which has many species, is widely distributed and is normally saprophytic; its spores are constantly present in the air. Nevertheless, the potential pathogenicity of the species fiumigatus, and to a smaller extent of some others, is well recognized in veterinary medicine; it is an important pathogen of birds, both wild and domesticated, infecting their lungs and air-sacs, and also of some mammals (Ainsworth & Austwick 1959) . In man, this species, and very occasionally some others, are associated with several types of bronchopulmonary disease (Hinson et al. 1952 ):
(1) The 'fungus ball' or aspergilloma, in which the mould colonizes an existing air-containing space in the lung. This occurrence does not depend upon any special reactivity in the host, but is followed by the appearance of large amounts of precipitating antibodies in the blood serum (Longbottom & Pepys 1964) , as would be expected from prolonged and intense antigenic stimulation of a non-atopic subject. It is thus not specially associated with asthma.
(2) Aspergillus may grow in devitalized or damaged lung, without producing any obvious clinical features: it has been found at necropsy growing in infarcts and in lungs affected by pneumoconiosis.
(3) It may behave as an opportunistic pathogen in patients whose defences against infection are depressed by diseases such as Hodgkin's disease and leukemias and by therapeutic procedures such as immunosuppressive drugs, corticosteroids and radiotherapy. In such instances, Aspergillus may not only actively invade the lungs, but also spread by the bloodstream to other organs.
(4) In atopic subjects, it may cause recurrent episodes of localized pulmonary infiltrations with blood eosinophilia. Nearly all these patients are extrinsic asthmatics. Specific hypersensitivity is a necessary antecedent to the development of the lung changes. In Britain, a high proportion of eosinophilic infiltrations in extrinsic asthmatics can be shown to be of this sort arid specifically related to Aspergillus fumigatus. Because these changes depend not only upon the presence of Aspergillus in the bronchi but also upon specific alterations of reactivity of the patient to Aspergillus, they may properly be called 'allergic bronchopulmonary aspergillosis'.
Clinical features of allergic aspergillosis: In most patients with asthma who develop allergic aspergillosis, the onset of the new phase of their illness is marked by a series of episodes in which such symptoms as fever, increase in cough and sputum, more severe asthma, and occasionally pleuritic pain lead to X-ray examination which shows transient or variable shadows in the lungs. These are generally of roughly segmental distribution, but may occasionally involve whole lobes. Usually the affected part shows irregular mottling; occasionally uniform consolidation is seen. These changes are accompanied by a moderate blood eosinophilia, the count usually being in the range 700-1,500/mm3. Sometimes during the course of such an episode, the patient notices the appearance in his sputum of 'plugs' of firmer consistence than the rest. They are usually rather spindle-shaped, 1-2 cm long, of colour ranging from yellow to brown; sometimes they show a little branching at one end, suggesting a cast of part of the bronchial tree. If they are examined microscopically after the usual histological staining, they are seen to consist principally of mucus and some fibrin, with many eosinophils. Only after special staining, e.g. by silver impregnation, will small amounts of fungal mycelium be found. Occasionally, a large 'plug' in sub-segmental or segmental bronchi produces a recognizable radiographic shadow, best seen in tomograms (see Fig 3) .
These episodes are usually self-terminating, but may last several weeks untreated. Since they are associated with fever, they are often treated with antibiotics if their true nature is unrecognized: this treatment probably has no effect, though spontaneous resolution may occur during treatment and be falsely interpreted as a response. The administration of a corticosteroid in effective dosage results in prompt resolution.
There is now abundant evidence that in the bronchi of segments which have been affected in allergic aspergillosis, a rather characteristic sort of bronchiectasis may develop (Scadding 1967) . This involves the proximal parts of segmental or sub-segmental bronchi, which show irregular dilatation. The dilated proximal parts communicate peripherally with normal small bronchi and bronchioles. In this respect the bronchiectasis associated with allergic aspergillosis differs from the usual forms of bronchiectasis in which bacterial inflammation plays a part; in these, the dilated bronchi commonly end blindly, as the result of an obliterative bronchiolitis (Fig 1) .
Since the episodes are usually transient, opportunities for histological study of the lung infiltration arise only rarely. When they have occurred, the changes have been found to be those of an eosinophilic pneumonia, alveoli being filled by a cellular exudate in which eosinophils are prominent. One of the 16 cases of eosinophilic pneumonia described by Liebow & Carrington (1969) appears to have been an example of allergic aspergillosis in an extrinsic atopic asthmatic. An example from the necropsy in the case of an extrinsic atopic asthmatic woman who died at the age of 50, having had both an aspergilloma in the residual cyst-like cavity left by a staphylococcal lung abscess and recurrent episodes of allergic aspergillosis, is shown in Fig 2. This combination of asthma, aspergilloma and allergic aspergillosis, which I have observed in Diagnosis of allergic bronchopulmonary aspergillosis depends first on recognition of the clinical and radiological picture; confirmation is obtained mainly from immunological studies. All patients show immediate Type I weal-andflare reactions to skin tests by the prick method to Aspergillus antigens; about 70% show weak precipitin lines in Ouchterlony double geldiffusion tests between blood serum and Aspergillus antigens (Longbottom & Pepys 1964) . Since Aspergillus appears in the sputum only intermittently in these cases, and may be found as a contaminant in a small proportion of all sputa, the finding of Aspergillus in sputum specimens is of itself of little significance; but the finding of a 'plug' in the sputum, having the characteristic histological appearances, is almost conclusive, especially if it is possible to culture Aspergillus from it.
Relationship ofallergic aspergillosis to asthma: In allergic aspergillosis, the relative prominence of the symptoms attributable to the lung infiltrations and of the asthma is very variable. In some cases, the asthma is the predominant feature, and attention is drawn to the possible role of Aspergillus only by the finding of a shadow in a routine radiograph, leading to appropriate immunological and other investigations. In most cases, distinguishable episodes occur in the course of established mild or moderate asthma. In a substantial minority, the episodes of eosinophilic infiltration are the leading feature, the patient being well or with only trivial asthma in the intervals between them; and a few patients are not overtly asthmatic.
Any attempt at estimating the relative frequency of these three groups is open to several obvious sources of error, including the difficulties of definition and the selected nature of any observer's experience. I quote my own experience only after this warning against generalizing from it. I have reviewed the records of 46 cases which I have categorized as allergic aspergillosis, on a combination of transient radiological infiltrations with blood eosinophilia, and supporting immunological findings. Because of the difficulty of deciding in a severe persistent asthmatic how important is the role of aspergillus hypersensitivity, I have included only those in which the symptoms associated with the transient infiltrations constituted an easily recognizable feature.
Of the 46 cases, 36 were patients who had had asthma for periods ranging from a few months to 44 years when the first episode of pulmonary infiltration was detected. Of these 36 patients, 27 had been asthmatic since before the age of 14; the age at which the first infiltration demonstrably due to aspergillosis developed ranged from 10 to 45 years. Among the remaining 9, whose asthma first appeared after childhood at ages ranging from 16 to 54 years, the first episode of infiltration was detected at ages ranging from 21 to 57 years.
Ten had no history of asthma at the time of the first episode of lung infiltration; 2 of these had had allergic rhinitis, seasonal in one and both seasonal and perennial in the other. All 10 All 46 patients showed strong immediate wealand-flare reactions in prick-tests of the skin with Aspergillus antigens. Most showed positive tests to one or more others from among the common inhalent allergens. A few, especially among those without preceding asthma, gave positive reactions to Aspergillus only.
There was a preponderance of the male sex among these 46 patients, especially among those without preceding asthma. Of the 36 with preceding asthma, 23 (64%) were male, while of the 10 without preceding asthma, 8 were male. With such small numbers, selective reference may have introduced a bias; of the 22 patients with an established diagnosis of allergic aspergillosis reported by Henderson (1968) , 15 were female.
In a severe asthmatic, there may be little in the clinical findings short of radiography to distinguish an episode of infiltration from a severe attack of asthma. For this reason, those patients without preceding asthma, though a minority, illustrate best the clinical features associated with the lung infiltrations.
One such patient was described at a meeting of the Clinical Section by McCarthy (1968) . This was a man who had had, over a period of 12 years, a series of episodes of fever, cough with purulent and sometimes bloodstained sputum, and the occasional production of 'plugs', with long symptom-free intervals. Only in the later episodes did he develop some wheezing. Immunological and mycological studies confirmed the diagnosis of allergic bronchopulmonary aspergillosis, and a bronchogram showed the characteristic proximal bronchiectasis at the sites of previous infiltrations. Fortunately a bronchogram after the first episode had shown normal bronchi, confirming that the bronchiectasis followed the episodes.
In a few patients without preceding asthma, episodes may be very infrequent, and separated by long symptom-free intervals. In the following case, there was an interval of 12 years between 2 well-defined episodes.
Case 1 A man aged 44, who had had mild allergic rhinitis for many years but no asthma, presented with a febrile illness with cough and slight wheeze. A chest radiograph showed some shadowing in the lower part of the upper zone of the right lung; tomography (Fig 3) showed this to be of irregular branching shape, the branching corresponding with that of the bronchi, though the outline was irregular and the width greater than that of normal bronchi in the relevant part of the lung. Shortly afterwards he coughed up several firm 'plugs' which were found to contain many eosinophils. Aspergillus fumigatus was isolated from the sputum; blood eosinophil counts of 800 and 1,160/mm3 were recorded; the skin reacted vigorously to prick-tests with Aspergillus, Cladosporium, Monilia and pollens, the site of the Aspergillus test remaining indurated for 5 days; bronchial challenge with Aspergillus produced wheezing after an interval of 12 hours; but no precipitins to Aspergillus were demonstrated in the blood. He was treated with inhalations of nebulized 1: 10,000 brilliant green. The radiographic shadow cleared within a few weeks; he continued to cough up 'plugs' for a time, and apart from one or two brief febrile illnesses, without radiographic changes in the lungs, he remained well until 12 years later. He then started to cough up 'plugs' again, but without wheezing. These were shown to contain Aspergillus fumigatus; the blood eosinophil count was 1,150/mm3; the skin again reacted vigorously to a prick test with Aspergillus; and on this occasion, precipitins to Aspergillus were demonstrated in the blood. In spite of reinstitution of brilliant green inhalations, a shadow developed in the apical segment of the left lower lobe (Fig 4) . This resolved promptly on treatment with prednisolone and did not recur when it was withdrawn.
Treatment is unsatisfactory. Since the reason why these patients develop symptoms is the specific hypersensitivity which they have developed to Aspergillus, desensitization would be the most radical form of treatment: unfortunately, no method of effecting this is known. Antifungal agents directed against Aspergillus have been tried; since the spores of this mould are constantly in the air, it is not surprising that the effect of these is doubtful. Aspergillus may be present in the bronchi only at the time of the episodes; and at these times, a small amount of mycelium is embedded in the centre of a 'plug' where it is inaccessible to drugs whether introduced by inhalation or by the bloodstream. The well-directed use of the suppressive effects of corticosteroids is at present the only effective way of treating patients with allergic bronchopulmonary aspergillosis.
In patients in whom the episodes are infrequent, it may be possible to control individual episodes by this means, and withdraw the corticosteroid when the episode is controlled. But it is necessary in many cases, unfortunately, to maintain continued suppression either because the episodes are frequently recurrent, or because the underlying asthma requires this sort of management. In any case, it seems important to control the episodes of allergic aspergillosis promptly and effectively because of the damage to bronchi that must be occurring where 'plugs' are lodged. In a few patients, disodium cromoglycate has been tried: usually it has been found to help their asthma, possibly reducing the maintenance dose of corticosteroid, but it has not removed the liability to fresh episodes of lung infiltration.
Prognosis: Of the 46 patients, followed up for periods ranging from 2 to 15 years from diagnosis of allergic aspergillosis, only 3 are known to have died, 2 with the very unfavourable additional factors of aspergilloma and secondary bacterial infection, already mentioned, and one in status asthmaticus. Among the rest, the degree of disability is variable, and determined in part by the severity of the asthma, and in part by such factors as permanent bronchopulmonary damage and secondary bacterial infection. In some patients, the liability to infiltrations seems to diminish over the years, irrespective of treatment.
Other causes of eosinophilic infiltrations in extrinsic asthmatics: Although it is certain that in Great Britain eosinophilic infiltrations in extrinsic asthmatics are most commonly associated with Aspergillus, and their immunology has been well elucidated, it remains possible that a minority of such infiltrations may be associated with similar hypersensitivity to other agents.
Eosinophilic Infiltrations in Intrinsic Asthmatics
In allergic aspergillosis the wide range of clinical features and of interrelations with extrinsic atopic asthma can be explained in general outline on the basis of recognizable antigen-antibody reactions. By contrast, the pathogenesis of eosinophilic infiltrations of the lungs in intrinsic asthmatics remains an unsolved problem.
I have personally observed 15 cases of intrinsic asthma with eosinophilic infiltrations, and one further case, in which eosinophilic infiltrations similar to those seen in intrinsic asthma developed in a patient whose asthma retained some of the features of the extrinsic atopic type. The following description is based upon these 16 cases, which amount to about one-third of the cases of allergic aspergillosis I have had under my care during the same period. It is probable that this ratio overestimates the relative frequency of intrinsic asthma with eosinophilic infiltrations, since the experience of one working in a specialist hospital is likely to include an abnormally high proportion of cases of rarer types of disease.
Eosinophilic infiltrations in intrinsic asthmatics are distinguished from those in extrinsic asthmatics not only by the absence of the positive immunological and other features that characterize the latter, but also by some important clinical and radiological differences.
Age: As already noted, intrinsic asthma usually starts after childhood. In 2 of the 16 patients, there was a history of mild asthmatic symptoms in childhood, with complete remission until asthma which had the features of the intrinsic type developed at the ages of 27 and 40 years. In the exceptional case, mentioned above, seasonal hay fever had been present since childhood; the first attack of asthma occurred at the age of 31, and the illness associated with lung infiltrations a year later. Reaginic hypersensitivity to pollens and to the house dust mite was demonstrated but could not be correlated with the lung infiltrations. With this exception, none of the patients showed evidence of reaginic hypersensitivities. One girl became asthmatic at the age of 13, and developed her first infiltration 10 months later. The ages of the rest at the onset of asthma ranged between 17 and 48 years. There was generally a shorter interval than in allergic aspergillosis between the beginning of asthma and the first evidence of infiltration; in 5, the asthma and the first infiltration were detected simultaneously, in 7 the infiltrations became apparent within a year of the asthma, and in the other 4 the intervals were 2, 3, 3 and I0 years.
Sex: There was a considerable female preponderance, only 4 of the 16 patients being men.
Eosinophilia: The blood eosinophil counts tended to be numbered in thousands rather than hundreds: the maximum recorded counts ranged up to 24,500/mm3, the mean being 7,000/mm3. The counts in many instances varied widely from time to time, even apart from the effects of treatment.
Radiology: Radiographically, the infiltrations differed from those observed in the eosinophilic infiltrations of extrinsic asthmatics, which, whether presenting homogeneous or mottled shadows, are generally relatable to bronchopulmonary segments or lobes. Infiltrations in intrinsic asthmatics present in two ways: as localized shadows, tending to appear and disappear without obvious reason, of non-segmental distribution and often smaller than a segment in size (Fig 7) , and as widespread shadows in a curious 'peripheral' distribution in the lung fields (Figs 5, 8, 11) . Carrington et al. (1969) have aptly described this as a 'photographic negative' of the shadow produc-d by pulmonary cedema. Of the 16 cases, 12 showed transient localized shadows, and 9 widespread peripheral shadowss 6 showing both types of shadow in different episodes; and one showed widespread coarse mottling in the lower parts of the lungs, at one stage almost confluent at the left base. In 3 cases, bronchograms performed after resolution of the infiltrations showed no abnormality; there was no suggestion of the proximal bronchiectasis that can develop as a result of allergic aspergillosis.
Immunology: Skin tests by the prick method with a wide range of the allergens most commonly associated with extrinsic asthma were performed in all cases, with negative results in all but the one mentioned above. In 7 cases, bronchial Response to corticosteroids and course: The 16 patients have been observed for periods ranging up to 15 years from their first infiltration. One died in status asthmaticus after 3 years, and another of renal failure from polyarteritis nodosa after one year. The mean period of observation after the first infiltration in the survivors is 9 years.
Without treatment, the infiltrations may remit; in 11 patients one or more episodes of infiltration were observed to remit in this way. But the more severe widespread 'peripheral' infiltrations tended to be accompanied by constitutional symptoms such as fever and tachycardia, and in most of these and some others the asthma was severe, so that treatment with a corticosteroid was considered necessary in all but one patient. In all patients treated with corticosteroids, there was prompt relief of symptoms and resolution of the radiographic shadows. In all but one, it has proved necessary to maintain treatment to control the asthma; the maintenance dose required in most cases is in the range 5-15 mg of prednisolone daily, with increases at times of increased symptoms.
Histology: Opportunities for histological study of the infiltrations associated with intrinsic asthma are rare. Several of the cases described as 'eosinophilic pneumonia' by Liebow & Carrington (1969) and by Carrington et al. (1969) Most of the cells in alveolar walls and many of those surrounding the small area ofgranular necrosis are eosinophils; the intraalveolar cells are mainly macrophages and eosinophils. Hand E.x 115 type; and in the one among my 16 cases in which biopsy material was available, the changes were essentially eosinophilic pneumonia with some granulomatous elements.
Case 2 A girl aged 17 developed asthma which was later found to be of intrinsic type; there were no previous respiratory symptoms and no family history of asthma, skin tests to the common inhalant allergens were all negative, and no Aspergillus precipitins were found. Three months from the onset, her asthma was severe, and she was found to have patchy consolidation in the lingula. Prednisolone, 40 mg daily, produced relief of symptoms and clearing of the radiographic shadow. When it was withdrawn, the asthma relapsed; she became very breathless, wheezy and febrile. Radiography now showed widespread peripheral mottled shadowing in both lungs ( Fig 5) . The leukocyte count was 12,000/mm3 with 19 % of eosinophils. Drill biopsy of the lung preduced a small fragment in which there was cellular infiltration including a high proportion of eosinophils in alveolar walls; some eosinophils and large phagocytic cells within the alveoli; and a small focus of necrosis surrounded by inflammatory cells (Fig 6) . Reinstitution of prednisolone treatment led to prompt resolution of the infiltration and relief of asthma. Four years later, she still requires prednisolone for control of the asthma, but no further infiltration has been observed.
Relationship of lung infiltrations to asthma: Just as in allergic aspergillosis, so in the eosinophilic infiltrations with intrinsic asthma the relative prominence of the infiltrations and of the asthma varies from case to case. This can best be illustrated by case-reports. Case 3 illustrates the larger group in which asthma is prominent.
Case 3 A woman, then aged 27, developed wheezy attacks with cough for the first time in autumn 1956. Transient localized shadows were seen in December 1956 in the upper zone of the right lung, and in April 1957 in the middle zone of the left lung (Fig 7) . She was referred to me in November 1957, because mottled shadowing had appeared in the middle zone of the right lung. She had lost 6 kg in weight since her illness began. The temperature was irregularly raised, up to 37 8°C. She was wheezy, with spirometric evidence of moderately severe airways obstruction. The radiographic changes spread further, showing early in December patchy shadows, mostly rather peripherally (Fig 8) . Eosinophils numbered 2,800 in a total blood leukocyte count of 17,000/mm3. Skin tests with the common inhalant allergens, and bronchial tests with grass pollen, Aspergillus, Cladosporium and Penicillium were all negative. Prednisolone 30 mg daily caused rapid relief of asthma and of cough, with cessation of expectoration, which had produced up to 100 ml of mucopurulent sputum daily; and concurrently the lung infiltrations cleared. She has subsequently needed maintenance on prednisolone, usually in dosage in the range 50-12-5 mg daily, for control of asthma; only one transient shadow, at the base of the right lung in January 1961, has been observed in the 13 years that have elapsed since I first saw her.
In Case 4 the infiltrations have been the most prominent feature.
Case 4 A woman aged 34, who had had no previous respiratory illness, developed a cough and evening fever; after a few weeks the cough became productive of a little yellow sputum, once blood-stained, and she was intermittently wheezy. Extensive radiographic opacities were found in the upper halves of both lungs (Fig 9) and blood eosinophilia ranging up to 13,000/ mm3. The sputum contained many eosinophils, and 'Creola bodies', small groups of desquamated ciliated epithelial cells characteristically associated with asthma, were found in it. The spleen was just palpable. The opacities cleared spontaneously, but further shadows appeared over the next few months in the middle zone of the left lung, and rather peripherally in the upper and middle zones of the right lung (Fig 10) . At this stage she was treated with prednisolone, with rapid relief of symptoms; but on withdrawal of this, cough, occasionally blood-stained I;... sputum, dyspneea and evening pyrexia recurred, and further opacities in the chest radiograph appeared. Thereafter, she has continued to develop similar symptoms and recurrence of radiographic shadows in the lungs whenever corticosteroid dosage is reduced below a critical level. Throughout, asthma is only one feature of the symptoms accompanying the infiltrations. All immunological investigations have proved negative. The range of iterrelations between intrinsic asthma and eosinophilic infiltrations can be completed by a few patients who have similar infiltrations without asthma. Carrington et al. (1969) have recently drawn attention to a small group of such patients. They described 9 patients, all female, in whom lung biopsies showed eosinophilic pneumonia; of these 6 had asthma, but 3 had neither asthma nor blood eosinophilia. All responded promptly to corticosteroid treatment, and those without asthma resembled those with asthma both histologically and in all respects save the absence of asthma and blood eosinophilia.
I have not personally seen a patient with this sort of eosinophilic pneumonia but without asthma, but Dr Arthur Landau, of Cape Town, has sent me the case-record of such a patient, and has kindly given me leave to quote it.
Case 5 A girl aged 19, who had had no important previous illness, became ill with fever, sore throat and dry cough but no wheezing. For 2 months these symptoms continued intermittently, the cough becoming productive of mucoid sputum; she lost 6 kg in weight. At this stage a chest radiograph showed patchy 'peripheral' shadowing in both lungs (Fig 11) ; the blood leukocyte count ranged from 19,000 to 27,000/mm3, with 9 % to 28 % of eosinophils. There was no response to antibiotics, although the infiltraticn later cleared partially without treatment. An open lung biopsy (Fig 12) showed extensive cellular infiltraticn of alveolar walls, the predominant cells being eosinophils and plasma cells, some eosinophils and pigment-laden macrophages in alveolar spaces, and, in places, cuboidal cells lining alveoli. Treatment with prednisone resulted in rapid relief of symptoms and clearance of the infiltration. She relapsed, with recurrence of the infiltration, 3 years later, when prednisone was stopped; treatment was reinstituted, with prompt response, and 5 years from the onset she was symptom-free on 7-5 mg of prednisone daily.
Associated systemic disease: It has long been known that some cases of polyarteritis nodosa start with asthma. Rose & Spencer (1957) , reviewing Il l cases, found that asthma was the first symptom in 12, and noted that it differed from the usual 'allergic' asthma in having started after childhood in all patients, in the absence of association with other recognized 'allergic' diseases, and in very high eosinophil counts in the peripheral blood. Nine of the 12 patients were female. All but one of them had radiologically evident lung changes, usually varying in extent and distribution under observation. Rose & Spencer recognized among their 111 patients a group of 32 in which the lungs were involved, and which included the 12 with asthma. These were characterized by blood eosinophilia, highest in those with asthma; respiratory symptoms preceding systemic manifestations for as long as 7 years; E B: in a few cases granulomas in the upper respiratory tract; and pathologically, more eosinophils and giant cells and more granulomatous lesions in and outside arter ics. Of my 16 cases of intrinsic asthma with eosinophilic infiltrations, one (Case 6) developed systemic polyarteritis and two (Cases 7 and 8) have had histological evidence of arteritic changes in biopsies from a single site.
Case 6 A man had his first attack of asthma at age 44; 18 months later he developed scattered papulovesicular skin lesions, some vesicles containing blood-stained fluid, high blood eosinophilia, and widespread mottled opacities in the lower halves of both lungs. The lung infiltrations and the asthma responded promptly to prednisolone, but proteinuria and rising blood urea soon appeared, and led to progressive renal failure of which he died within a year of the first appearance of the infiltration (see Scadding 1958, Case 3).
Case 7 A woman aged 50 with intrinsic asthma, blood eosinophilia reaching 9,000/mm3 and a characteristic widespread peripheral pattern of lung infiltration, was found to have polyarteritis in a random muscle biopsy; her symptoms were controlled by prednisolone. There was no recurrence of the infiltraticn nor clinical evidence of systemic polyarteritis, but con- tinued prednisolone treatment was required for the control of the asthma; she died in status asthmaticus three years later, no necropsy being performed.
Case 8 A girl aged 13 developed intrinsic-type asthma with blood eosinophilia reaching 6,800/mm3; a year later transient shadows appeared in the lungs. One in the upper zone of the left lung disappeared spontaneously within a month. Shortly afterwards a thin-walled cyst-like cavity appeared in the middle zone of the right lung, and persisted for 4 weeks; prcdnisolone 30 mg daily was then given successfully for the relief of the asthma, and the 'cyst' disappeared. Over the next 3 years, she required prednisolone in dosage ranging from 7 to 15 mg daily for control of the asthma. She then developed abdominal pain; an emergency appendicectomy was performed, and both the appendix (Fig 13) and a nodule removed from the cxecal region showed several vessels with typical periarteritis nodosa and much eosinophil infiltration.
Case 9 A man aged 33 developed severe intrinsic-type asthma with transient localized infiltrations in both lungs, and blood eosinophil count ranging up to 5,700/mm3. Biopsy of a peculiar rash, consisting of a widespread erythema with raised edges resembling urticaria, showed very extensive infiltration of the media and adventitia of dermal vessels with cells, mostly eosinophils. Prednisolone was given for control of the asthma; the rash and the lung infiltration cleared and have not recurred, though thirteen years later he still requires prednisolone, as much as 20 to 30 mg daily, to control the asthma.
Conclusions
Eosinophilic infiltrations, presumably due to eosinophilic pneumonias, occur in association with both extrinsic atopic and intrinsic asthma; but there are important clinical, radiological and immunological differences between these two groups.
The majority of eosinophilic infiltrations occurring in extrinsic atopic asthmatics in Great Britain can be shown to be a response to the mould Aspergillus; and their immunological basis is understood, at least in general outline. They can pro;erly be describcd as a manifestation of allergic bronchopulmonary aspergillosis. Rarely, this disease may occur in patients without overt asthma; but even in this minority, evidence of an atopic constitution is generally discoverable.
In intrinsic asthmatics, eosinophilic infiltrations present different radiological appearances from those seen in allergic bronchopulmonary aspergillosis, and are not associated with the changes in segmental bronchi that may occur in that disease. Eosinophilic infiltrations of the sort associated with intrinsic asthma occur predominantly, but not exclusively, in the female sex. In a small minority of patients with such infiltrations, systemic arteritic lesions are found, occasionally amounting to generalized polyarteritis. The pathogenesis of these infiltrations is unknown. This is not surprising, since very little is known about the cause or causes of intrinsic asthma. On the negative side, no evidence of reaginic hypersensitivity can be demonstrated in patients with intrinsic asthma, and they do not show the elevation of serum levels of IgE which occurs in extrinsic asthmatics (Johansson 1967) . It has been shown that a higher proportion of them than of either extrinsic asthmatics or control subjects have demonstrable circulating autoantibodies, both organ-specific and non-organspecific (Hall et al. 1966 , Turner-Warwick & Dawson 1971 ; in this they resemble certain other diseases of unknown cause, such as cryptogenic fibrosing alveolitis. This may be evidence that the patient with intrinsic asthma has a predisposition, possibly inborn, to develop an as yet unelucidated sort of allergic reaction, which plays an essential role not only in the asthma, but also in the eosinophilic infiltrations associated with it. This role would be analogous to that of the well-recognized Type I reactions underlying extrinsic atopic asthma and contributing to the eosinophilic infiltrations of allergic bronchopulmonary aspergillosis. And just as an occasional case of the latter disease is seen in a patient without overt asthma, but generally with evidence of atopy, so the rare case of eosinophilic infiltration having the clinical and radiological features of those associated with intrinsic asthma is seen in a patient without asthma; and in such a case, it is legitimate to speculate whether the type of allergic reaction, as yet unelucidated, which underlies intrinsic asthma is a factor in the pathogenesis of the eosinophilic pneumonia.
Finally, the recognition that the eosinophilic infiltrations that occur ipi extrinsic and in intrinsic asthmatics are clearly distinguishable is important, not only for its practical clinical implications, but also because it provides further evidence of the validity of the distinction already made on other grounds between these two groups of asthmatic patients.
